U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116070) titled 'Sarcopenia and Related Factors in Patients With Multiple Sclerosis' on July 24.
Brief Summary: Multiple Sclerosis (MS) is a chronic disease affecting the central nervous system, exhibiting autoimmune and neurodegenerative properties. Neurological deficits, mobility limitations, and decreased muscle strength are commonly observed in MS patients as the disease progresses. The literature indicates that low physical activity levels and neurological deficits in individuals with MS can lead to decreased muscle mass and functional losses. Sarcopenia is a condition characterized by decreased skeletal muscle mass and strength associated with...